| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/26/2013 | CN101915844B Method and special quantum dot fluorescent immunoassay kit for detecting quinolone compounds |
| 06/26/2013 | CN101668774B Anti-ip-10 antibodies and methods of use thereof |
| 06/26/2013 | CN101639477B ELISA detection method for doxycycline remnant, kit and application |
| 06/26/2013 | CN101611058B Prlr-specific antibody and uses thereof |
| 06/26/2013 | CN101454441B Human embryonic stem cell methods and podxl expression |
| 06/25/2013 | US8470991 Immunocytokine sequences and uses thereof |
| 06/25/2013 | US8470980 Extracellular targeted drug conjugates |
| 06/25/2013 | US8470979 Humanized antibody molecules specific for IL-31 |
| 06/25/2013 | US8470978 Method for separating viable cells, apoptotic and dead cells |
| 06/25/2013 | US8470977 Antibody against the CSF-1R |
| 06/25/2013 | US8470970 Mammalian sweet and amino acid heterodimeric taste receptors comprising T1R3 and T1R1 |
| 06/25/2013 | US8470782 Transglutaminase inhibitors and methods of use thereof |
| 06/25/2013 | US8470774 Deoxycorticosterone induced elastin production |
| 06/25/2013 | US8470593 Plasmid system for multigene expression |
| 06/25/2013 | US8470543 Methods for differentiating and monitoring parathyroid and bone status related diseases |
| 06/25/2013 | US8470335 Recombinant SARS-CoV nsp12 and the use of thereof and the method for producing it |
| 06/25/2013 | US8470334 Method of inducing an antiviral immune response against HIV-1 utilizing chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics |
| 06/25/2013 | US8470328 Purification method which prevents denaturation of an antibody |
| 06/25/2013 | US8470327 Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof |
| 06/25/2013 | US8470326 Monoclonal antibody therapy for pancreas cancer |
| 06/25/2013 | US8470325 Method of treating amykloidosis comprising administering an anti-HMGB-1 antibody |
| 06/25/2013 | US8470324 Fusion polypeptides capable of activating receptors |
| 06/25/2013 | US8470322 Anti sulfatides and anti sufated proteoglycans antibodies and their use |
| 06/25/2013 | US8470321 Antibodies specific for the protofibril form of beta-amyloid protein |
| 06/25/2013 | US8470318 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 06/25/2013 | US8470317 B7RP-1 antagonists |
| 06/25/2013 | US8470315 Non-natural ribonuclease conjugates as cytotoxic agents |
| 06/25/2013 | CA2648274C Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same |
| 06/25/2013 | CA2573586C Il-17 antagonistic antibodies |
| 06/25/2013 | CA2573505C N-glycosylated antibody |
| 06/25/2013 | CA2545255C Interleukin-10 antibodies |
| 06/25/2013 | CA2522894C Pharmaceutical composition comprising a bispecific antibody specific for epcam |
| 06/25/2013 | CA2496422C Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor |
| 06/25/2013 | CA2495725C Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody |
| 06/25/2013 | CA2454578C Modified human thymic stromal lymphopoietin |
| 06/25/2013 | CA2347849C Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof |
| 06/25/2013 | CA2214453C Novel avian cytokines and genetic sequences encoding same |
| 06/20/2013 | WO2013090644A2 Anti-hiv antibodies having increased potency and breadth |
| 06/20/2013 | WO2013090635A2 Composition and method for the diagnosis and treatment of iron-related disorders |
| 06/20/2013 | WO2013090633A2 Composition and method for the diagnosis and treatment of iron-related disorders |
| 06/20/2013 | WO2013090478A1 Predicting responsiveness to antibody maintenance therapy |
| 06/20/2013 | WO2013089647A1 Binding molecules against dengue virus and uses thereof |
| 06/20/2013 | WO2013089496A1 Broad-spectrum neutralizing monoclonal antibody having high potential derived from h1n1-infected patients, and composition containing same for treating the virus |
| 06/20/2013 | WO2013089477A1 A method of antibody purification |
| 06/20/2013 | WO2013089166A1 Fimbriae type of porphyromonas gulae |
| 06/20/2013 | WO2013088587A1 Recombinant protein capable of binding to troponin-i from human cardiac muscle specifically and rapidly |
| 06/20/2013 | WO2013088378A2 Method of detecting the presence of an antibody in a sample |
| 06/20/2013 | WO2013088363A1 Chimeric therapeutic anti - cd37 antibodie hh1 |
| 06/20/2013 | WO2013088304A1 Combination of inotuzumab ozogamicin and torisel for the treatment of cancer |
| 06/20/2013 | WO2013088164A1 Thrombin-binding antibody molecules and uses thereof |
| 06/20/2013 | WO2013088136A1 Ligand for dngr-1 receptor |
| 06/20/2013 | WO2013088111A1 Use of antibody |
| 06/20/2013 | WO2013087993A1 Glycoprotein |
| 06/20/2013 | WO2013087992A1 Glycoprotein |
| 06/20/2013 | WO2013087914A1 EXPRESSION OF SECRETORY IgA ANTIBODIES IN DUCKWEED |
| 06/20/2013 | WO2013087913A1 Compounds and methods for treating inflammatory diseases |
| 06/20/2013 | WO2013087912A1 Compounds and methods for treating inflammatory diseases |
| 06/20/2013 | WO2013087911A1 Compounds and methods for treating inflammatory diseases |
| 06/20/2013 | WO2013087874A1 Antibodies against the cytolethal distending toxin of c. difficile |
| 06/20/2013 | WO2013087857A2 Antibodies against c. difficile toxins |
| 06/20/2013 | WO2013087785A2 Bowman-birk protease inhibitor (bbi) binding peptides, and uses thereof in the separation, detection or purification of bbi |
| 06/20/2013 | WO2013087699A1 Antibodies against human csf-1r and uses thereof |
| 06/20/2013 | WO2013086636A1 Soluble igf receptor fc fusion proteins and uses thereof |
| 06/20/2013 | WO2013070615A8 Combination therapies using anti- pseudomonas psl and pcrv binding molecules |
| 06/20/2013 | WO2013063613A3 Methods and compositions related to intracellular neutralization by igg |
| 06/20/2013 | WO2013060867A3 Production of heterodimeric proteins |
| 06/20/2013 | WO2013055874A3 Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab |
| 06/20/2013 | WO2013052582A3 Generation of antibodies to an epitope of interest that contains a phosphomimetic amino acid |
| 06/20/2013 | WO2013045404A3 Inhibition of interleukin 1 beta for treating endometriosis |
| 06/20/2013 | WO2013038375A3 Methods for making saccharide-protein glycoconjugates |
| 06/20/2013 | WO2012040562A3 Novel hiv-1 broadly neutralizing antibodies |
| 06/20/2013 | US20130158238 Compositions and Methods for the Therapy and Diagnosis of Influenza |
| 06/20/2013 | US20130158237 Recombinant protein capable of binding specifically and quickly to troponin i derived from human myocardium |
| 06/20/2013 | US20130158236 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 06/20/2013 | US20130158234 Specific binding agents of human angiopoietin-2 |
| 06/20/2013 | US20130158233 Method for simultaneously detecting an antigen of, and an antibody, against, an infectious microorganism |
| 06/20/2013 | US20130157354 Transgenic non-human animals for producing chimeric antibodies |
| 06/20/2013 | US20130157313 High affinity antibodies to human il-6 receptor |
| 06/20/2013 | US20130157311 Methods of Determination of Activation or inactivation of Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP) Hormonal Systems |
| 06/20/2013 | US20130157310 Method for Production and Use of Mite Group 1 Proteins |
| 06/20/2013 | US20130157296 Recombinant protein capable of binding specifically and quickly to troponin i dervived from human myocardium |
| 06/20/2013 | US20130157294 Methods and Compositions for the Diagnosis of Cancer Susceptibilities and Defective DNA Repair Mechanisms and Treatment Thereof |
| 06/20/2013 | US20130157289 Immuno-pet imaging of antibodies and immunoconjugates and uses therefor |
| 06/20/2013 | US20130157255 Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism |
| 06/20/2013 | US20130156806 Antigenic Polypeptides of Trichinella and Uses Thereof |
| 06/20/2013 | US20130156789 Antibodies against human angiopoietin 2 |
| 06/20/2013 | US20130156788 Fully human antibodies specific to cadm1 |
| 06/20/2013 | US20130156786 Peptide or peptide complex binding to 2 integrin and methods and uses involving the same |
| 06/20/2013 | US20130156785 Novel diagnostic and therapeutic target in inflammatory and/or cardiovascular diseases |
| 06/20/2013 | US20130156782 Monoclonal Antibodies for Treatment of Cancer |
| 06/20/2013 | US20130156781 Anti-dr4 agonist antibodies |
| 06/20/2013 | US20130156780 Annexin 1 Antibody |
| 06/20/2013 | US20130156779 Novel antigen binding proteins |
| 06/20/2013 | US20130156778 Dendritic cell inhibitory proteins from ticks |
| 06/20/2013 | US20130156777 Glipr1 inhibitors and therapeutic uses thereof |
| 06/20/2013 | US20130156776 Compositions and methods for treating cancer and modulating stress granule formation |
| 06/20/2013 | US20130156775 Chlamydia trachomatis antigens |
| 06/20/2013 | US20130156774 Bi-specific antibodies against tim-3 and pd-1 for immunotherapy in chronic immune conditions |
| 06/20/2013 | US20130156772 Bispecific Anti ErbB1 / Anti cMet Antibodies |
| 06/20/2013 | US20130156771 Fdf03 antibodies and uses thereof |